Acute Leukemia of Ambiguous Lineage - 35 Studies Found
Terminated |
: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia :
|
Completed |
: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia :
|
Recruiting |
: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes :
|
Recruiting |
: Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies :
|
Recruiting |
: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant :
|
Recruiting |
: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease :
|
Recruiting |
: Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention :
|
Suspended |
: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer :
|
Recruiting |
: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide :
|
Completed |
: AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia : Leukemia : 2011-09-08 :
|